Compositions for modulating SOD-1 expression

    公开(公告)号:US10968453B2

    公开(公告)日:2021-04-06

    申请号:US16849583

    申请日:2020-04-15

    Applicant: Biogen MA Inc.

    Inventor: Eric E. Swayze

    Abstract: Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).

    Compositions for modulating SOD-1 expression

    公开(公告)号:US10385341B2

    公开(公告)日:2019-08-20

    申请号:US15301004

    申请日:2015-04-01

    Applicant: Biogen MA Inc.

    Inventor: Eric E. Swayze

    Abstract: Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).

    Compositions for modulating SOD-1 expression

    公开(公告)号:US10669546B2

    公开(公告)日:2020-06-02

    申请号:US16513297

    申请日:2019-07-16

    Applicant: Biogen MA Inc.

    Inventor: Eric E. Swayze

    Abstract: Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).

    COMPOSITIONS FOR MODULATING SOD-1 EXPRESSION

    公开(公告)号:US20200040342A1

    公开(公告)日:2020-02-06

    申请号:US16513297

    申请日:2019-07-16

    Applicant: Biogen MA Inc.

    Inventor: Eric E. Swayze

    Abstract: Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).

Patent Agency Ranking